Table 3.
Inflammatory markers levels by treatment allocation as median and interquartile range.
| Time point | Level | IL-6 (pg/ml) |
CRP (mg/l) |
||
|---|---|---|---|---|---|
| Anakinra | Placebo | Anakinra | Placebo | ||
| Baseline | N | 14 8.5 (6.3, 12.5) |
9 (5.5,12.6) |
14 4.1 (1.3, 6.2) |
9 4.8 (2.3, 6.9) |
| Day 1 | N | 13 7.6 (2.8, 12.1) |
9 16.8 (5.3, 28.5) |
13 5.5 (2.6, 10.3) |
9 11.6 (3.4, 18.1) |
| Day 2 | N | 11 5.7 (3.4, 12.6) |
9 13.2 (9.0, 22.9) |
11 3.2 (2.3, 13.9) |
9 36.7 (10.9, 43.3) |
| Day 3 | N | 10 6.1 (2.8, 8.2) |
6 9.7 (5.7, 41.3) |
10 3.2 (1.2, 14.6) |
6 30.3 (10.0, 102.2) |
| Day 4 | N | 5 6.2 (5.1, 6.3) |
5 8.7 (5.2, 17.5) |
5 18.9 (6.7, 20.0) |
5 21.3 (7.4, 61.5) |